SIGN-UP NOW! SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More
top banner

C. diff. Spores and More

Tuesday at 10 AM Pacific

March 06th 2018:Encore: FIRVANQ 'TM' Newly Approved Vancomycin Oral Solution

Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution.

Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guest

Guest Image

Neal I. Muni, MD, MSPH

Dr. Muni joined CutisPharma as President in July 2014 and was named Chief Executive Officer in May 2015. Prior to joining CutisPharma, Dr. Muni served as the head of Corporate Strategy at Sunovion Pharmaceuticals. Prior to joining Sunovion, Dr. Muni worked as a consultant in the healthcare investment bank Leerink Swann, LLC. Prior to that, Dr. Muni was a Medical Officer in the Division of Cardiovascular Devices at the FDA, serving as the lead medical reviewer for coronary drug-eluting stents. Dr. Muni practiced as an Internist with the Hospitalist Group of the Department of Medicine at Brigham and Women’s Hospital and Harvard Medical School for over 15 years, completing his residency at th
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 10/12/2018 08:00 10/12/2018 09:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution. VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY Add to Calendar
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
GPlus Facebook Twitter Linkedin Social Media
presspass-banner